The contractor shall carry out activities required for the optimization, development, and synthesis of lead candidates and analogs, which may include resynthesis, acquisition, or purchase of…
Ended Awarded Last action
- Contract number
- 75N93020F00004
- Awardee
-
Southern Research Institute UEI CDZJAJJHJMH5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $494,934
Award facts
- Contract value 100% obligated
- $494,934.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Birmingham, AL 35205, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$3,368 | |
| Original award | $498,302 |
About this award
This federal contract award is for the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases. The prime contractor is Southern Research Institute, a non-profit organization that provides advanced technologies and contract research services, including drug discovery and development, emerging infectious disease research, medicinal chemistry, and toxicology.
The contract, with a potential value of $494,934.25, is for the optimization, development, and synthesis of lead candidates and analogs for in vitro testing of HIV therapeutics and topical microbicides. The contract is a delivery order and is priced on a cost-plus-fixed-fee basis. There is no set-aside designation. The contract has a completion date of July 31, 2021.
Description
The contractor shall carry out activities required for the optimization, development, and synthesis of lead candidates and analogs, which may include resynthesis, acquisition, or purchase of compounds.
Quick answers
Who was awarded contract 75N93020F00004?
75N93020F00004 was awarded to Southern Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 1, 2020.
How much is contract 75N93020F00004 worth?
The government has obligated $494,934 on 75N93020F00004.
Is contract 75N93020F00004 an order under another contract?
Yes. 75N93020F00004 is a delivery order under HHSN272201400010I, an indefinite delivery contract.
Was contract 75N93020F00004 competed?
The extent of competition for 75N93020F00004 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award